| Year |
Citation |
Score |
| 2022 |
Martinuzzi LJ, Strassnig MT, Depp CA, Moore RC, Ackerman R, Pinkham AE, Harvey PD. A closer look at avolition in schizophrenia and bipolar disorder: Persistence of different types of activities over time. Schizophrenia Research. 250: 188-195. PMID 36436498 DOI: 10.1016/j.schres.2022.11.019 |
0.427 |
|
| 2022 |
Morgan O, Strassnig MT, Moore RC, Depp CA, Ackerman RA, Pinkham AE, Harvey PD. Accuracy of immediate self-assessment of neurocognitive test performance: Associations with psychiatric diagnosis and longitudinal psychotic symptoms. Journal of Psychiatric Research. 156: 594-601. PMID 36372002 DOI: 10.1016/j.jpsychires.2022.10.069 |
0.417 |
|
| 2021 |
Miller ML, Strassnig MT, Bromet E, Depp CA, Jonas K, Lin W, Moore RC, Patterson TL, Penn DL, Pinkham AE, Kotov RA, Harvey PD. Performance-based assessment of social skills in a large sample of participants with schizophrenia, bipolar disorder and healthy controls: Correlates of social competence and social appropriateness. Schizophrenia Research. 236: 80-86. PMID 34425381 DOI: 10.1016/j.schres.2021.08.012 |
0.337 |
|
| 2021 |
Strassnig MT, Harvey PD, Miller ML, Depp CA, Granholm E. Real world sedentary behavior and activity levels in patients with schizophrenia and controls: An ecological momentary assessment study. Mental Health and Physical Activity. 20. PMID 34221125 DOI: 10.1016/j.mhpa.2020.100364 |
0.471 |
|
| 2021 |
Strassnig MT, Miller ML, Moore R, Depp CA, Pinkham AE, Harvey PD. Evidence for avolition in bipolar disorder? A 30-day ecological momentary assessment comparison of daily activities in bipolar disorder and schizophrenia. Psychiatry Research. 300: 113924. PMID 33848963 DOI: 10.1016/j.psychres.2021.113924 |
0.398 |
|
| 2021 |
Durand D, Strassnig MT, Moore RC, Depp CA, Ackerman RA, Pinkham AE, Harvey PD. Self-reported social functioning and social cognition in schizophrenia and bipolar disorder: Using ecological momentary assessment to identify the origin of bias. Schizophrenia Research. 230: 17-23. PMID 33667854 DOI: 10.1016/j.schres.2021.02.011 |
0.383 |
|
| 2021 |
Miller ML, Strassnig MT, Bromet E, Depp CA, Jonas K, Lin W, Moore RC, Patterson TL, Penn DL, Pinkham AE, Kotov RA, Harvey PD. Performance-based assessment of social skills in a large sample of participants with schizophrenia, bipolar disorder and healthy controls: Correlates of social competence and social appropriateness Schizophrenia Research. 236: 80-86. DOI: 10.1016/j.schres.2021.08.012 |
0.301 |
|
| 2021 |
Durand D, Strassnig M, Moore R, Depp C, Pinkham A, Harvey P. Social Functioning and Social Cognition in Schizophrenia and Bipolar Disorder: Using Ecological Momentary Assessment to Identify the Origin of Bias Self Reports Biological Psychiatry. 89: S131-S132. DOI: 10.1016/j.biopsych.2021.02.339 |
0.417 |
|
| 2020 |
Strassnig M, Jones MT, Pinkham A, Penn D, Jarskog LF, Harvey PD. Depression, hostility, attributional biases, and paranoia in schizophrenia and healthy controls: intercorrelations and associations with self-assessment of social functioning. Psychiatry Research. 293: 113388. PMID 32866794 DOI: 10.1016/J.Psychres.2020.113388 |
0.571 |
|
| 2020 |
Jones MT, Strassnig MT, Harvey PD. Emerging 5-HT receptor antagonists for the treatment of Schizophrenia. Expert Opinion On Emerging Drugs. PMID 32449404 DOI: 10.1080/14728214.2020.1773792 |
0.546 |
|
| 2020 |
Strassnig M, Harvey P, Depp C, Granholm E. Smartphone-Based Assessment of Real-World Sedentary Behavior in Schizophrenia Biological Psychiatry. 87: S339-S340. DOI: 10.1016/J.Biopsych.2020.02.871 |
0.593 |
|
| 2019 |
Strassnig MT, Nascimento V, Deckler E, Harvey PD. Pharmacological treatment of violence in schizophrenia. Cns Spectrums. 1-9. PMID 31342892 DOI: 10.1017/S1092852919001226 |
0.56 |
|
| 2019 |
Harvey PD, Strassnig MT. Cognition and disability in schizophrenia: cognition-related skills deficits and decision-making challenges add to morbidity. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 18: 165-167. PMID 31059625 DOI: 10.1002/Wps.20647 |
0.556 |
|
| 2019 |
Mahncke HW, Kim SJ, Rose A, Stasio C, Buckley P, Caroff S, Duncan E, Yasmin S, Jarskog LF, Lamberti JS, Nuechterlein K, Strassnig M, Velligan D, Ventura J, Walker T, et al. Evaluation of a plasticity-based cognitive training program in schizophrenia: Results from the eCaesar trial. Schizophrenia Research. PMID 30930034 DOI: 10.1016/J.Schres.2019.03.006 |
0.488 |
|
| 2019 |
Harvey PD, Strassnig MT, Silberstein J. Prediction of disability in schizophrenia: Symptoms, cognition, and self-assessment Journal of Experimental Psychopathology. 10: 204380871986569. DOI: 10.1177/2043808719865693 |
0.594 |
|
| 2019 |
Strassnig M, Harvey P, Holden J, Mikhael T, Depp C, Granholm E. O6.6. REAL WORLD SEDENTARY BEHAVIOR AND ACTIVITY LEVELS IN PATIENTS WITH SCHIZOPHRENIA AND CONTROLS DERIVED FROM ECOLOGICAL MOMENTARY ASSESSMENT Schizophrenia Bulletin. 45: S178-S178. DOI: 10.1093/Schbul/Sbz021.222 |
0.554 |
|
| 2018 |
Strassnig M, Bowie C, Pinkham AE, Penn D, Twamley EW, Patterson TL, Harvey PD. Which levels of cognitive impairments and negative symptoms are related to functional deficits in schizophrenia? Journal of Psychiatric Research. 104: 124-129. PMID 30029051 DOI: 10.1016/J.Jpsychires.2018.06.018 |
0.617 |
|
| 2018 |
Strassnig M, Kotov R, Fochtmann L, Kalin M, Bromet EJ, Harvey PD. Associations of independent living and labor force participation with impairment indicators in schizophrenia and bipolar disorder at 20-year follow-up. Schizophrenia Research. PMID 29472164 DOI: 10.1016/J.Schres.2018.02.009 |
0.579 |
|
| 2018 |
Strassnig M, Pinkham A, Penn D, Harvey P. T251. Severity of Impairment in Cognition and Negative Symptoms and Their Relation With Functional Deficits Biological Psychiatry. 83: S227. DOI: 10.1016/J.Biopsych.2018.02.588 |
0.534 |
|
| 2017 |
Strassnig M, Rosenfeld A, Harvey PD. Tardive dyskinesia: motor system impairments, cognition and everyday functioning. Cns Spectrums. 1-8. PMID 28877766 DOI: 10.1017/S1092852917000542 |
0.522 |
|
| 2017 |
Strassnig M, Cornacchio D, Harvey PD, Kotov R, Fochtmann L, Bromet EJ. Health status and mobility limitations are associated with residential and employment status in schizophrenia and bipolar disorder. Journal of Psychiatric Research. 94: 180-185. PMID 28743064 DOI: 10.1016/J.Jpsychires.2017.07.011 |
0.592 |
|
| 2017 |
Strassnig M, Kotov R, Cornaccio D, Fochtmann L, Harvey PD, Bromet EJ. Twenty-year progression of body mass index in a county-wide cohort of people with schizophrenia and bipolar disorder identified at their first episode of psychosis. Bipolar Disorders. PMID 28574189 DOI: 10.1111/Bdi.12505 |
0.553 |
|
| 2017 |
Strassnig M, Kotov R, Fochtmann L, Harvey P, Bromet E. 216. 20-Year Progression of BMI in a County-Wide Cohort People with Schizophrenia and Bipolar Disorder Identified at Their First Episode of Psychosis Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.229 |
0.604 |
|
| 2015 |
Strassnig MT, Signorile JF, Potiaumpai M, Romero MA, Gonzalez C, Czaja S, Harvey PD. High velocity circuit resistance training improves cognition, psychiatric symptoms and neuromuscular performance in overweight outpatients with severe mental illness. Psychiatry Research. 229: 295-301. PMID 26187340 DOI: 10.1016/J.Psychres.2015.07.007 |
0.562 |
|
| 2015 |
Sabbag S, Prestia D, Robertson B, Ruiz P, Durand D, Strassnig M, Harvey PD. Absence of bias in clinician ratings of everyday functioning among African American, Hispanic and Caucasian patients with schizophrenia. Psychiatry Research. 229: 347-52. PMID 26160197 DOI: 10.1016/J.Psychres.2015.06.042 |
0.542 |
|
| 2015 |
Strassnig MT, Raykov T, O'Gorman C, Bowie CR, Sabbag S, Durand D, Patterson TL, Pinkham A, Penn DL, Harvey PD. Determinants of different aspects of everyday outcome in schizophrenia: The roles of negative symptoms, cognition, and functional capacity. Schizophrenia Research. 165: 76-82. PMID 25868935 DOI: 10.1016/J.Schres.2015.03.033 |
0.588 |
|
| 2015 |
Strassnig M, Clarke J, Mann S, Remington G, Ganguli R. Body composition, pre-diabetes and cardiovascular disease risk in early schizophrenia. Early Intervention in Psychiatry. PMID 25752319 DOI: 10.1111/eip.12225 |
0.355 |
|
| 2015 |
Durand D, Strassnig M, Sabbag S, Gould F, Twamley EW, Patterson TL, Harvey PD. Factors influencing self-assessment of cognition and functioning in schizophrenia: implications for treatment studies. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 185-91. PMID 25104226 DOI: 10.1016/J.Euroneuro.2014.07.008 |
0.555 |
|
| 2015 |
Potiaumpai M, Romero MA, Signorile JF, Harvey PD, Gonzalez CM, Strassnig M. Measures Of Physical Function In Patients With Persistent Mental Illness After High-velocity Circuit Resistance-training Medicine & Science in Sports & Exercise. 47: 678. DOI: 10.1249/01.Mss.0000478571.20691.7A |
0.454 |
|
| 2015 |
Romero MA, Potiaumpai M, Signorile JF, Harvey PD, Gonzalez CM, Strassnig M. The Effects of an 8-Week High Velocity Resistance Circuit Training Program in Patients with Schizophrenia Medicine & Science in Sports & Exercise. 47: 667. DOI: 10.1249/01.Mss.0000478541.74056.6D |
0.549 |
|
| 2014 |
Strassnig MT, Harvey PD. Treatment resistance and other complicating factors in the management of schizophrenia. Cns Spectrums. 19: 16-23; quiz 13-5, 24. PMID 25410772 DOI: 10.1017/S1092852914000571 |
0.526 |
|
| 2014 |
Strassnig M, Signorile J, Gonzalez C, Harvey PD. Physical performance and disability in schizophrenia. Schizophrenia Research. Cognition. 1: 112-121. PMID 25254158 DOI: 10.1016/J.Scog.2014.06.002 |
0.628 |
|
| 2014 |
Vargas G, Strassnig M, Sabbag S, Gould F, Durand D, Stone L, Patterson TL, Harvey PD. The course of vocational functioning in patients with schizophrenia: Re-examining social drift. Schizophrenia Research. Cognition. 1: e41-e46. PMID 25254157 DOI: 10.1016/J.Scog.2014.01.001 |
0.631 |
|
| 2014 |
Depp CA, Strassnig M, Mausbach BT, Bowie CR, Wolyniec P, Thornquist MH, Luke JR, McGrath JA, Pulver AE, Patterson TL, Harvey PD. Association of obesity and treated hypertension and diabetes with cognitive ability in bipolar disorder and schizophrenia. Bipolar Disorders. 16: 422-31. PMID 24725166 DOI: 10.1111/Bdi.12200 |
0.582 |
|
| 2013 |
Strassnig M, Harvey PD. Treatment of obesity and disability in schizophrenia. Innovations in Clinical Neuroscience. 10: 15-9. PMID 24062969 |
0.626 |
|
| 2012 |
Strassnig M, Brar JS, Ganguli R. Health-related quality of life, adiposity, and sedentary behavior in patients with early schizophrenia: preliminary study. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 5: 389-394. PMID 23152691 DOI: 10.2147/Dmso.S33619 |
0.449 |
|
| 2012 |
Strassnig MT, Newcomer JW, Harvey PD. Exercise improves physical capacity in obese patients with schizophrenia: pilot study. Schizophrenia Research. 141: 284-5. PMID 22959487 DOI: 10.1016/j.schres.2012.08.011 |
0.357 |
|
| 2012 |
Harvey PD, Strassnig M. Predicting the severity of everyday functional disability in people with schizophrenia: cognitive deficits, functional capacity, symptoms, and health status. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 11: 73-9. PMID 22654932 DOI: 10.1016/J.Wpsyc.2012.05.004 |
0.654 |
|
| 2012 |
Strassnig MT, Caceda R, Newcomer JW, Harvey PD. Cognitive deficits, obesity and disability in schizophrenia Translational Neuroscience. 3: 345-354. DOI: 10.2478/S13380-012-0046-5 |
0.631 |
|
| 2011 |
Strassnig M, Brar JS, Ganguli R. Low cardiorespiratory fitness and physical functional capacity in obese patients with schizophrenia. Schizophrenia Research. 126: 103-9. PMID 21146958 DOI: 10.1016/j.schres.2010.10.025 |
0.433 |
|
| 2007 |
Riedel M, Müller N, Strassnig M, Spellmann I, Severus E, Möller HJ. Quetiapine in the treatment of schizophrenia and related disorders. Neuropsychiatric Disease and Treatment. 3: 219-35. PMID 19300555 DOI: 10.2147/nedt.2007.3.2.219 |
0.382 |
|
| 2007 |
Riedel M, Spellmann I, Strassnig M, Douhet A, Dehning S, Opgen-Rhein M, Valdevit R, Engel RR, Kleindienst N, Müller N, Möller HJ. Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms. European Archives of Psychiatry and Clinical Neuroscience. 257: 360-70. PMID 17629731 DOI: 10.1007/s00406-007-0739-x |
0.412 |
|
| 2007 |
Riedel M, Müller N, Spellmann I, Engel RR, Musil R, Valdevit R, Dehning S, Douhet A, Cerovecki A, Strassnig M, Möller HJ. Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 257: 402-12. PMID 17629725 DOI: 10.1007/s00406-007-0748-9 |
0.449 |
|
| 2007 |
Strassnig M, Ganguli R. Weight Loss Interventions for Patients with Schizophrenia Clinical Schizophrenia & Related Psychoses. 1: 43-53. DOI: 10.3371/Csrp.1.1.3 |
0.482 |
|
| 2006 |
Strassnig M, Brar JS, Ganguli R. Increased caffeine and nicotine consumption in community-dwelling patients with schizophrenia. Schizophrenia Research. 86: 269-75. PMID 16859897 DOI: 10.1016/j.schres.2006.05.013 |
0.304 |
|
| 2005 |
Strassnig M, Brar JS, Ganguli R. Dietary intake of patients with schizophrenia. Psychiatry (Edgmont (Pa. : Township)). 2: 31-5. PMID 21179633 |
0.421 |
|
| 2005 |
Riedel M, Müller N, Strassnig M, Spellmann I, Engel RR, Musil R, Dehning S, Douhet A, Schwarz MJ, Möller HJ. Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms. European Archives of Psychiatry and Clinical Neuroscience. 255: 432-7. PMID 16267634 DOI: 10.1007/s00406-005-0622-6 |
0.395 |
|
| 2005 |
Riedel M, Strassnig M, Schwarz MJ, Müller N. COX-2 inhibitors as adjunctive therapy in schizophrenia: rationale for use and evidence to date. Cns Drugs. 19: 805-19. PMID 16185091 DOI: 10.2165/00023210-200519100-00001 |
0.414 |
|
| 2005 |
Strassnig M, Brar JS, Ganguli R. Self-reported body weight perception and dieting practices in community-dwelling patients with schizophrenia. Schizophrenia Research. 75: 425-32. PMID 15885533 DOI: 10.1016/j.schres.2004.04.007 |
0.377 |
|
| 2005 |
Spellmann I, Riedel M, Müller N, Strassnig M, Douhet A, Dehning S, Möller H. Cognitive benefits of quetiapine versus risperidone in schizophrenia Pharmacopsychiatry. 38. DOI: 10.1055/S-2005-918844 |
0.52 |
|
| 2003 |
Strassnig M, Brar JS, Ganguli R. Nutritional assessment of patients with schizophrenia: a preliminary study. Schizophrenia Bulletin. 29: 393-7. PMID 14552512 DOI: 10.1093/oxfordjournals.schbul.a007013 |
0.425 |
|
| 2003 |
Brar J, Strassnig M, Ganguli R. Smoking, caffeine intake and eating habits in community dwelling patients with schizophrenia Schizophrenia Research. 60: 34. DOI: 10.1016/S0920-9964(03)80097-X |
0.32 |
|
| Show low-probability matches. |